Search Clinical Pathways
Evaluation of Suspected Acute Flaccid Myelitis Clinical Pathway — Emergency and Inpatient
This pathway guides the care of children who present with onset of flaccid weakness in one or more extremities +/- bulbar/cranial nerve findings without other clear cause.
Unprovoked Seizure Clinical Pathway — Emergency Department
The unprovoked seizure clinical pathway outlines the steps to standardize the ED clinical assessment, evaluation and recommend Neurology follow-up for healthy children presenting with new onset unprovoked seizure(s).
Emergency Department and Inpatient Mitochondrial Clinical Pathway
This pathway guides the ED and inpatient care for patients of any age with Genetically confirmed, Primary (Definite) Mitochondrial Disease or Suspected Mitochondrial Disease.
Somatic Symptom and Related Disorders (SSRD) Clinical Pathway — Emergency Department and Inpatient
This pathway guides the diagnosis of Somatic Symptom and Related Disorders (SSRD) where the history/physical of a patient’s chief complaint does not align with known organic medical causes.
Croup Clinical Pathway — Emergency Department and Inpatient
The croup pathway highlights the care necessary in treating children with croup in the emergency department and inpatient settings.
Spinal Cord Injury (SCI) Clinical Pathway — Emergency Department and ICU
The suspected traumatic spinal cord injury clinical pathway outlines the care plan for assessment and treatment of spinal cord injury in the emergency department and ICU.
Brief Resolved Unexplained Event Clinical Pathway — Emergency and Inpatient
Emergency Department pathway for infant presenting with a brief, resolved, concerning event.
Multisystem Inflammatory Syndrome (MIS-C) Clinical Pathway — Emergency, ICU and Inpatient
Multisystem Inflammatory Syndrome (MIS-C), ED, ICU and Inpatient
COVID-19 Screening Clinical Pathway — Emergency
The ED Coronavirus Pathway provides guidance for the evaluation and care of patients with laboratory-confirmed 2019-nCoV or who is under investigation for 2019-nCoV while that patient was ill.
Active COVID-19, Clinical Pathway — All Settings
Treatment of patients with active COVID-19 disease with guidance on severity of illness, recommendations for antivirals, steroids, immunomodulators, and convalescent plasma administration.